Health Catalyst, Inc.
Health Catalyst, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 61 | 60 | 51 | 40 | 51 | 342 | 250 | 328 | 202 | 201 | 106 | 95 | |||||
Short Term Investments | 43 | 49 | 45 | 51 | 47 | 0 | 142 | 59 | 106 | 126 | 211 | 253 | |||||
Accounts Receivable Net Current | 42 | 59 | 59 | 60 | 68 | 64 | 57 | 52 | 55 | 54 | 60 | 46 | |||||
Prepaid Expense And Other Assets Current | 12 | 14 | 14 | 14 | 15 | 17 | 16 | 19 | 13 | 15 | 15 | 15 | |||||
Assets Current | 248 | 182 | 169 | 165 | 181 | 423 | 466 | 457 | 376 | 397 | 393 | 408 | |||||
Property Plant And Equipment Net | 33 | 35 | 34 | 33 | 33 | 32 | 29 | 28 | 26 | 25 | 26 | 26 | |||||
Intangible Assets Net Excluding Goodwill | 56 | 69 | 78 | 90 | 98 | 106 | 86 | 76 | 67 | 66 | 73 | 72 | |||||
Operating Lease Right Of Use Asset | 6 | 6 | 7 | 7 | 12 | 12 | 12 | 11 | 2 | 12 | 14 | 15 | |||||
Goodwill | 11 | 113 | 209 | 286 | 286 | 313 | 260 | 234 | 206 | 191 | 191 | 186 | |||||
Other Assets Noncurrent | 4 | 6 | 6 | 7 | 5 | 6 | 6 | 6 | 5 | 4 | 5 | 5 | |||||
Assets | 359 | 412 | 503 | 587 | 616 | 892 | 859 | 813 | 692 | 695 | 702 | 713 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 8 | 12 | 9 | 5 | 9 | 9 | 11 | 14 | 11 | 6 | 7 | 6 | |||||
Contract With Customer Liability Current | 43 | 70 | 56 | 59 | 67 | 71 | 53 | 52 | 56 | 64 | 56 | 53 | |||||
Operating Lease Liability Current | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | |||||
Business Combination Contingent Consideration Liab… | - | - | - | - | - | - | - | - | 1 | - | - | - | |||||
Senior Notes | - | - | - | - | - | - | - | - | 229 | - | - | - | |||||
Long Term Debt Current | 2 | 2 | 2 | 2 | 2 | 232 | 231 | 230 | - | - | 0 | - | |||||
Liabilities Current | 92 | 108 | 90 | 88 | 99 | 340 | 326 | 324 | 318 | 92 | 89 | 84 | |||||
Long Term Debt Noncurrent | 152 | 152 | 152 | 152 | 151 | 151 | 151 | 115 | 0 | 228 | 228 | 228 | |||||
Contract With Customer Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 13 | 13 | 14 | 15 | 16 | 16 | 16 | 16 | 17 | 17 | 18 | 18 | |||||
Business Combination Contingent Consideration Liab… | 0 | 0 | 0 | 0 | 2 | 7 | 0 | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | |||||
Liabilities | 258 | 274 | 257 | 255 | 269 | 515 | 494 | 458 | 335 | 338 | 335 | 331 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stocks Including Additional Paid In Capital | 1,616 | 1,613 | 1,609 | 1,604 | 1,597 | 1,587 | 1,553 | 1,521 | 1,508 | 1,495 | 1,484 | 1,469 | |||||
Retained Earnings Accumulated Deficit | -1,516 | -1,476 | -1,365 | -1,274 | -1,251 | -1,210 | -1,187 | -1,166 | -1,151 | -1,138 | -1,117 | -1,087 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 1 | 1 | 2 | 2 | 2 | 0 | -1 | -0 | -0 | -0 | 0 | -0 | |||||
Stockholders Equity | 101 | 138 | 246 | 332 | 348 | 377 | 365 | 355 | 357 | 357 | 367 | 382 | |||||
Liabilities And Stockholders Equity | 359 | 412 | 503 | 587 | 616 | 892 | 859 | 813 | 692 | 695 | 702 | 713 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | |||||
Common Stock Shares Issued | 75 | 74 | 72 | 71 | 70 | 69 | 64 | 61 | 60 | 59 | 58 | 57 | |||||
Shares Outstanding | 75 | 74 | 72 | 71 | 70 | 69 | 64 | 61 | 60 | 59 | 58 | 57 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 39.86% | 50.72% | 51.45% | - | - | - | - | - | - | - | - | - |
| 2025 | -7.99% | -7.75% | -6.05% | 19.79% | -1.06% | 14.49% | -8.77% | -20.00% | -24.56% | -34.64% | -18.99% | -22.91% |
| 2024 | 3.43% | -0.31% | 20.59% | -4.77% | 10.07% | 1.46% | -0.34% | -20.09% | -34.88% | -10.73% | -22.27% | -17.81% |
| 2023 | - | - | - | -5.94% | -18.78% | -44.94% | 5.11% | 27.90% | 42.27% | -7.67% | -28.10% | -24.32% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.70 | 1.69 | 1.89 | 1.88 | 1.83 | 1.24 | 1.43 | 1.41 | 1.18 | 4.31 | 4.42 | 4.85 | |||||
| Quick Ratio | 2.58 | 1.56 | 1.73 | 1.73 | 1.68 | 1.20 | 1.38 | 1.36 | 1.14 | 4.14 | 4.25 | 4.67 | |||||
| Working Capital | 156.47M | 74.70M | 79.73M | 77.46M | 81.75M | 83.16M | 139.80M | 133.63M | 58.04M | 304.93M | 304.36M | 324.20M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 2.56 | 1.98 | 1.05 | 0.77 | 0.77 | 1.37 | 1.35 | 1.29 | 0.94 | 0.95 | 0.91 | 0.86 | |||||
| Interest Coverage TTM | -14.40 | -14.38 | -9.81 | -6.41 | -7.88 | -6.87 | -7.97 | -6.69 | -6.95 | -10.03 | -13.94 | -50.19 | |||||
| Debt Ratio | 0.72 | 0.66 | 0.51 | 0.43 | 0.44 | 0.58 | 0.57 | 0.56 | 0.48 | 0.49 | 0.48 | 0.46 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.60 | 0.46 | 0.46 | 0.45 | 0.48 | 0.39 | 0.39 | 0.40 | 0.42 | 0.41 | 0.41 | 0.39 | |||||
| Days Sales Outstanding TTM | 68.87 | 74.33 | 68.22 | 64.53 | 71.17 | 69.14 | 69.93 | 59.05 | 65.37 | 71.17 | 66.76 | 60.18 | |||||
| Receivables Turnover TTM | 5.30 | 4.91 | 5.35 | 5.66 | 5.13 | 5.28 | 5.22 | 6.18 | 5.58 | 5.13 | 5.47 | 6.07 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -3.58 | -3.65 | -2.55 | -1.53 | -1.44 | -1.06 | -1.15 | -1.31 | -1.46 | -1.80 | -2.09 | -2.18 | |||||
| Free Cash Flow Per Share TTM | 0.11 | 0.23 | -0.03 | -0.22 | -0.13 | 0.04 | 0.22 | -0.04 | -0.08 | -0.31 | -0.61 | -0.53 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 50.48% | 49.89% | 48.75% | 46.50% | 45.31% | 45.24% | 45.92% | 45.22% | 44.92% | 44.64% | 44.55% | 45.65% | |||||
| Operating Profit Margin TTM | -84.36% | -81.71% | -51.70% | -29.19% | -27.98% | -21.58% | -22.77% | -28.17% | -32.05% | -38.68% | -42.88% | -45.12% | |||||
| Net Profit Margin TTM | -90.61% | -87.69% | -57.20% | -34.05% | -31.67% | -23.34% | -22.67% | -26.20% | -28.87% | -35.56% | -39.92% | -42.62% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -7.54% | -2.83% | 1.48% | 4.64% | 5.55% | 4.88% | 3.60% | 4.15% | 5.23% | 5.24% | 7.13% | 6.71% | |||||
| Net Income Growth (1Y) | 164.50% | 265.08% | 156.07% | 35.99% | 15.82% | -31.16% | -41.17% | -35.98% | -41.32% | -28.75% | -14.01% | -17.92% | |||||
| EPS Growth (1Y) | 149.00% | 244.76% | 120.49% | 16.79% | -1.35% | -41.16% | -44.85% | -39.93% | -44.61% | -32.53% | -18.12% | -21.41% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.56 | -0.35 | -0.94 | -1.86 | -2.62 | -4.27 | -6.12 | -6.22 | -4.38 | -4.18 | -4.42 | -4.64 | |||||
| P/B TTM | 1.46 | 0.67 | 0.68 | 0.60 | 0.76 | 0.82 | 1.17 | 1.39 | 1.06 | 1.24 | 1.42 | 1.50 | |||||
| P/S TTM | 0.50 | 0.30 | 0.54 | 0.63 | 0.83 | 1.00 | 1.39 | 1.63 | 1.27 | 1.49 | 1.77 | 1.98 | |||||
| Market Cap | 147.18M | 92.19M | 167.05M | 200.57M | 262.49M | 310.54M | 425.51M | 491.99M | 378.95M | 441.19M | 522.43M | 573.91M | |||||
| Enterprise Value | 240.07M | 185.69M | 269.49M | 313.41M | 364.80M | 351.43M | 558.22M | 508.69M | 405.85M | 468.24M | 644.19M | 706.60M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 8.46M | 16.53M | -2.04M | -15.23M | -9.00M | 2.50M | 12.94M | -2.41M | -4.95M | -18.25M | -34.32M | -30.26M | |||||
| Net Debt | 92.89M | 93.50M | 102.44M | 112.83M | 102.32M | 40.89M | 132.72M | 16.71M | 26.90M | 27.04M | 121.76M | 132.68M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Health Catalyst, Inc. (HCAT) — SEC Financial Statements & Analysis
Health Catalyst, Inc. (HCAT) is a services-computer programming, data processing, etc. company, incorporated in DE. Health Catalyst, Inc. trades on Nasdaq as: HCAT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Health Catalyst, Inc. reported a -7.54% year-over-year revenue growth, a Gross Profit Margin of 50.48% (TTM), a Debt-to-Equity ratio of 2.56x, a Price-to-Sales (P/S) ratio of 0.50x (TTM), a Price-to-Book (P/B) ratio of 1.46x (TTM), at a market cap of $147.18M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -7.54%
- Gross Profit Margin TTM
- 50.48%
- Debt To Equity
- 2.56x
- P/S TTM
- 0.50x
- P/B TTM
- 1.46x
- Market Cap
- $147.18M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Health Catalyst, Inc. in?
Health Catalyst, Inc. (HCAT) operates in the Services-Computer Programming, Data Processing, Etc. industry.
What is HCAT's market cap?
Health Catalyst, Inc. (HCAT) has a market capitalization of $147.18M as of 2026-06-30.
What exchange does HCAT trade on?
Health Catalyst, Inc. (HCAT) trades on the Nasdaq.
Where is Health Catalyst, Inc. incorporated?
Health Catalyst, Inc. is incorporated in DE.